These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23025688)

  • 41. Characterization of Autoantigens Targeted by Anti-Citrullinated Protein Antibodies In Vivo: Prominent Role for Epitopes Derived from Histone 4 Proteins.
    Meng X; Ezzati P; Smolik I; Bernstein CN; Hitchon CA; El-Gabalawy HS
    PLoS One; 2016; 11(10):e0165501. PubMed ID: 27788229
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relatedness of Antibodies to Peptides Containing Homocitrulline or Citrulline in Patients with Rheumatoid Arthritis.
    Lac P; Racapé M; Barra L; Bell DA; Cairns E
    J Rheumatol; 2018 Mar; 45(3):302-309. PubMed ID: 29196382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.
    Farid SSh; Azizi G; Mirshafiey A
    Int J Rheum Dis; 2013 Aug; 16(4):379-86. PubMed ID: 23992255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
    van Wesemael TJ; Ajeganova S; Humphreys J; Terao C; Muhammad A; Symmons DP; MacGregor AJ; Hafström I; Trouw LA; van der Helm-van Mil AH; Huizinga TW; Mimori T; Toes RE; Matsuda F; Svensson B; Verstappen SM; van der Woude D
    Arthritis Res Ther; 2016 Dec; 18(1):285. PubMed ID: 27906045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes.
    Goëb V; Thomas-L'Otellier M; Daveau R; Charlionet R; Fardellone P; Le Loët X; Tron F; Gilbert D; Vittecoq O
    Arthritis Res Ther; 2009; 11(2):R38. PubMed ID: 19284558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis.
    Koivula MK; Aman S; Alasaarela E; Karjalainen A; Hakala M; Risteli J
    Rheumatology (Oxford); 2006 Nov; 45(11):1364-9. PubMed ID: 16632481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.
    Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR
    J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
    Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
    J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
    Feitsma AL; van der Voort EI; Franken KL; el Bannoudi H; Elferink BG; Drijfhout JW; Huizinga TW; de Vries RR; Toes RE; Ioan-Facsinay A
    Arthritis Rheum; 2010 Jan; 62(1):117-25. PubMed ID: 20039411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope and smoking status in Brazilian patients with rheumatoid arthritis.
    Yazbek MA; Barros-Mazon Sd; Rossi CL; Londe AC; Costallat LT; Bertolo MB
    Clinics (Sao Paulo); 2011; 66(8):1401-6. PubMed ID: 21915491
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities.
    Ioan-Facsinay A; el-Bannoudi H; Scherer HU; van der Woude D; Ménard HA; Lora M; Trouw LA; Huizinga TW; Toes RE
    Ann Rheum Dis; 2011 Jan; 70(1):188-93. PubMed ID: 20736390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis.
    García-Moreno C; Gómara MJ; Bleda MJ; Sanmartí R; Haro I
    PLoS One; 2019; 14(5):e0215927. PubMed ID: 31048864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physical Characteristics of a Citrullinated Pro-Filaggrin Epitope Recognized by Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Sera.
    Trier NH; Holm BE; Slot O; Locht H; Lindegaard H; Svendsen A; Houen G
    PLoS One; 2016; 11(12):e0168542. PubMed ID: 28002483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive Profiling of the Rheumatoid Arthritis Antibody Repertoire.
    Lo KC; Sullivan E; Bannen RM; Jin H; Rowe M; Li H; Pinapati RS; Cartwright AJ; Tan JC; Patel J; Keystone EC; Siminovitch KA
    Arthritis Rheumatol; 2020 Feb; 72(2):242-250. PubMed ID: 31449733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The ACPA recognition profile and subgrouping of ACPA-positive RA patients.
    Willemze A; Böhringer S; Knevel R; Levarht EW; Stoeken-Rijsbergen G; Houwing-Duistermaat JJ; van der Helm-van Mil AH; Huizinga TW; Toes RE; Trouw LA
    Ann Rheum Dis; 2012 Feb; 71(2):268-74. PubMed ID: 21998120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
    Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z
    Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation.
    Ytterberg AJ; Joshua V; Reynisdottir G; Tarasova NK; Rutishauser D; Ossipova E; Haj Hensvold A; Eklund A; Sköld CM; Grunewald J; Malmström V; Jakobsson PJ; Rönnelid J; Padyukov L; Zubarev RA; Klareskog L; Catrina AI
    Ann Rheum Dis; 2015 Sep; 74(9):1772-7. PubMed ID: 24817415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
    Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
    Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.